Yuko Hosoe

Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer

Junzo Hamanishi, Masaki Mandai, Takafumi Ikeda et al. · Journal of Clinical Oncology · 2015 · 1.2K citations

Medicine, Oncology, Pharmacology +17

Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer

Peng Jin, Junzo Hamanishi, Noriomi Matsumura et al. · Cancer Research · 2015 · 522 citations

Medicine, Immunology, Oncology +17

Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation

Mana Taki, Kaoru Abiko, Tsukasa Baba et al. · Nature Communications · 2018 · 309 citations · Full text

Medicine, Immunology, Oncology +17

VISTA expressed in tumour cells regulates T cell function

Kumuluzi Mulati, Junzo Hamanishi, Noriomi Matsumura et al. · British Journal of Cancer · 2018 · 205 citations · Full text

Medicine, Immunology, Oncology +17

CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer

Masayo Ukita, Junzo Hamanishi, Hiroyuki Yoshitomi et al. · JCI Insight · 2022 · 190 citations · Full text

Medicine, Immunology, Oncology +17